当前位置: 首页 > 期刊 > 《中国医学创新》 > 2023年第31期
编号:2440917
心外膜脂肪组织在心血管疾病中研究进展
http://www.100md.com 2023年12月29日 中国医学创新 2023年第31期
     【摘要】 心外膜脂肪组织(epicardial adipose tissue,EAT)在心血管疾病(cardiovascular disease,CVD)发展过程中起着重要作用,最近EAT越来越受到关注。EAT是位于心肌和心外膜内脏层之间的一个独特脂肪库,它是一种可量化的、可改变的组织,具有局部和全身效应的脂肪组织。EAT在一定程度参与心房颤动(atrial fibrillation,AF)、冠心病(coronary heart disease,CHD)、心力衰竭(heart failure,HF)的发生发展。在这篇综述中,将讨论EAT的解剖结构和生理功能以及与心血管疾病的关系,还讨论了EAT的测量方法和干预EAT的治疗方法。

    【关键词】 心外膜脂肪 冠心病 房颤 心力衰竭

    Research Progress of Epicardial Adipose Tissue in Cardiovascular Diseases/WANG Zhao, DIAO Shuling. //Medical Innovation of China, 2023, 20(31): -170

    [Abstract] Epicardial adipose tissue (EAT) plays an important role in the development of cardiovascular disease (CVD). Recently, EAT has attracted more and more attention. EAT is a unique fat pool between the heart muscle and the visceral layer of the epicardium. It is a quantifiable and changeable tissue with local and systemic effects. EAT is involved in the occurrence and development of atrial fibrillation (AF), coronary heart disease (CHD) and heart failure (HF) to a certain extent. In this review, we will discuss the anatomical structure and physiological function of EAT and its relationship with cardiovascular diseases ......

您现在查看是摘要页,全文长 19384 字符